Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-01-09 Sale |
2024-01-11 5:04 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,812 | $16.33 | $45,915 | 205,605 (Direct) |
View |
| 2023-05-15 Sale |
2023-05-17 4:58 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
11,965 | $29.03 | $347,358 | 257,591 (Direct) |
View |
| 2023-04-17 Sale |
2023-04-19 7:45 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
49,579 | $30.54 | $1,513,942 | 269,556 (Direct) |
View |
| 2023-03-16 Sale(A) |
2023-03-24 6:45 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
54,627 | $31.87 | $1,741,200 | 360,385 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-20 8:25 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
54,627 | $31.87 | $1,741,200 | 200,089 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-10 7:22 pm |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,034 | $36.3 | $73,831 | 204,299 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-15 Exercise |
2023-05-17 4:58 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
9,764 | $6.88 | 257,591 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 4:58 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,201 | $0.37 | 257,591 (Direct) |
View |
| 2023-05-15 Exercise |
2023-05-17 4:58 pm |
N/A 2029-03-18 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
11,965 | $0 | 257,591 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 7:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
4,718 | $6.88 | 269,556 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 7:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
44,861 | $0.37 | 269,556 (Direct) |
View |
| 2023-04-17 Exercise |
2023-04-19 7:45 pm |
N/A 2029-03-18 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
49,579 | $0 | 269,556 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
2,789 | $0.33 | 360,385 (Direct) |
View |
| 2023-03-16 Option Award(A) |
2023-03-24 6:45 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
50,417 | $0 | 360,385 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
16,748 | $6.88 | 360,385 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
30,041 | $0.37 | 360,385 (Direct) |
View |
| 2023-03-16 Exercise(A) |
2023-03-24 6:45 pm |
N/A 2028-02-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
49,578 | $0 | 360,385 (Direct) |
View |
| 2023-03-16 Option Award |
2023-03-20 8:25 pm |
N/A 2033-03-16 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
50,417 | $0 | 200,089 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-10 8:34 pm |
N/A 2032-01-06 |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
155,833 | $0 | 333,833 (Direct) |
View |
Ownership |
2022-01-06 5:02 pm |
N/A N/A |
Amylyx Pharmaceuticals Inc. | AMLX | Yeramian Patrick D Chief Medical Officer |
0 | $0 | 338,296 (Direct) |
View |